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Abstract In vivo targeted gene transfer by non-viral vectors is 
subjected to anatomical constraints depending on the route of 
administration. Transfection efficiency and gene expression in 
vivo using non-viral vectors is also relatively low. We report that 
in vivo electropermeabilization f the liver tissue of rats in the 
presence of genes encoding luciferase or ~-galactosidase r sulted 
in the strong expression of these genetic markers in rat liver cells. 
About 31)-40% of the rat liver cells electroporated expressed the 
~galactosidase genetic marker 48 h after electroporation. The 
marker expression was also detected at least 21 days after 
transfection at about 5% of the level 48 h after electroporation. 
The results indicate that gene transfer by electroporatinn in vivo 
may avoid anatomical constraints and low transfection effi- 
ciency. 
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I. Introduction 
Nonviral delivery of DNA in vivo is a subject of intensive 
study. With the goal of targeted gene delivery, anionic lipo- 
somes were first used [1,2]. Low transfection efficiency and 
transient gene expression characterized these first attempts; 
nevertheless, they indicated the feasibility of targeted DNA 
delivery to specific liver cells following i.v. liposome injection 
[2]. Targeting of liposomes with monoclonal antibodies direct- 
ed against surface antigens of hepatoma cells proved quite 
successful in vitro, but expression of genes encapsulated in 
these liposomes is not very efficient [3]. The introduction of 
cationic liposomes has increased the efficiency of DNA deliv- 
ery and demonstrated enhanced gene expression in vitro [4], 
and recently, in vivo [5,6]. Even if cationic liposomes could be 
efficiently targeted in vivo to specific cells, they would be 
subjected, like all types of liposomes, to the usual anatomical 
constraints depending on the route of administration [7]. A 
method of efficient DNA delivery to any specific tissue in 
vivo, overriding the anatomical constraints, might lead to use- 
ful therapeutical pplications of gene transfer. In 1982, Neu- 
mann et al. [8] demonstrated that in vitro electroporation of 
cells in the presence of plasmid DNA resulted in DNA trans- 
fer and expression. Since then, this method has become a 
widely used technique for in vitro transfection [9]. The mech- 
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anism of DNA transfer, using this approach, is based on for- 
mation of membrane pores followed by DNA electrophoresis 
into the cells [10]. 
Electroporation has been used in vivo, in animals and pa- 
tients [11-13], primarily to introduce anti-tumor drugs into 
cancer cells. Given the in vitro efficiency of this method of 
gene transfer, it appeared as a potentially efficient approach to 
target in vivo transfection. Using the liver of anesthetized rats 
as a model organ for gene delivery and expression, we inves- 
tigated the applicability of electroinjection to the liver tissues 
for in vivo gene therapy. 
2. Materials and methods 
2.1. Plasmids 
The expressing vector pSV-~-galactosidase carrying the I]-gal gene 
under the control of SV40 promoter was purchased from Promega 
(Madison, WI). 
2.2. Plasmid expressing firefly luciferase 
The BamHI-XhoI fragment carrying the Luc coding sequence from 
pGEM-Luc (Promega) was cloned into the pRc/CMV plasmid (Invi- 
trogen, San Diego, CA) between corresponding restriction sites, under 
the control of the CMV promoter. 
2.3. Electrode and electric pulse delivery 
Electric pulses were delivered using a rectangular direct current 
(DC) generator (T820; BTX, Inc.; San Diego, CA) and a switch 
box (195-7460; BTX, Inc., San Diego, CA). Six pulses were delivered 
to each animal at a rate of one pulse per s. Each pulse was 99 ~s in 
duration, and an electric field strength of 1000 V/cm was used unless 
otherwise specified. Pulses were administered to the tissue using a 
needle-array electrode (878-2a; BTX, Inc., San Diego, CA). Each 
array consisted of a cylindrical epoxy body with a circumferentially 
arranged set of six 28 gauge stainless-steel acupuncture needles pro- 
truding from one end. The needles were equispaced around a 1 cm 
diameter circle; each needle had an independent electrical connection. 
The switch box and needle array were used to deliver pulses from the 
DC generator. Pulses were monitored using a digital storage oscillo- 
scope (PM3375; Philips, Eindhoven, The Netherlands). Pulse data 
were transferred, using an IEEE 488 interface bus and custom-written 
software, to a personal computer for analysis. 
2.4. DNA electroinjection 
Male Sprague Dawley rats (Harlan, Indianapolis, IN) were weighed 
on a digital top loading scale. A 3 mg/kg dose of atropine sulfate 
(WAB10125, The Butler Co., Columbus, OH) was administered sub- 
cutaneously into the left flank using a 0.5 inch, 30 gauge needle. 10 
min later a 45 mg/kg dose of sodium pentobarbital (WAB10505, The 
Butler Co.) was injected into the peritoneal cavity using a 0.5 inch, 30 
gauge needle. After the animals were completely anesthetized, the liver 
was exposed by making a transverse incision starting from the mid- 
sagittal position, approx. 1 cm caudal to the xiphoid process, extend- 
ing 34  cm toward the dorsal surface of the rat. The median lobe 
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(both halves) of the liver was exposed by drawing it out of the incision 
taking precautions not to cause any tissue damage. 
Gene transfer was performed by injecting the desired quantity of 
gene (luciferase or 13-galactosidase) in 100 Itl of normal saline just 
beneath the surface of the right median lobe. The entire dose was 
injected at a single location in the center of the lobe. A period of 
1.5 min was allowed to pass in order to allow dissemination of the 
gene. Next, the electrode was placed into the tissue. Great care was 
taken to insert the electrode needles so that their annular pattern 
completely surrounded the injection point. Pulses, in the form of a 
rotating electric field, were administered immediately after the elec- 
trode was placed. The location of the electrode was marked using 
sutures in order to allow the treatment area to be later identified 
for biopsy. Animals were closed following gene transfer by suturing 
the abdominal muscles together and then stapling the skin incision. 
Expression was determined in tissue samples from the treatment 
sites. These samples were taken by first killing the animals by deliver- 
ing a 100 mg/kg dose of sodium pentobarbital. Then, the right median 
lobe was exposed as described above. Next, the treatment area was 
identified (to the extent possible) using the sutures that remained in 
the lobe to mark the location. Finally, an 11 mm diameter biopsy 
punch was used to remove a core (full thickness) of tissue that was 
encompassed by the needle array. Samples for luciferase xpression 
were frozen rapidly by emersion into liquid nitrogen and analyzed 
approx. 12 h after biopsy. Samples for I~-galactosidase expression 
were stored at 4°C in phospate-buffered saline for 12 h before analy- 
sis. 
2.5. Luciferase expression 
Luciferase expression was measured using a TD20E luminometer 
(Turner Design, Sunnyvale, CA) and a luciferase detection kit with Co 
A-luciferin as substrate (Promega, Madison, WI). The level of lucifer- 
ase expression was quantified using commercial firefly luciferase (Sig- 
ma, St. Louis, MO). Freshly prepared enzyme solution was aliquoted 
and stored at -86°C. Serial dilutions of the enzyme were prepared 
from a frozen aliquot and stored on ice during each experiment with 
liver tissue. The level of luminescence corresponding to the known 
activity of luciferase in serial dilutions was measured before and after 
each experiment to compensate for the possible denaturation of the 
enzyme. Additionally, serial dilutions of the enzyme were prepared in 
the tissue homogenate of normal rat liver in order to compensate for 
the adsorption of the enzyme and its proteolytic degradation by the 
tissue homogenate. Neither significant adsorption or degradation/in- 
activation of luciferase was detected in these experiments. 
2.6. Flow cytometric analysis of ~l-gal expression 
The rat liver was perfused with PBS, and the electroinjected liver 
tissue (about 0.5 g) was removed. The tissue was dissociated in ice- 
cold PBS with syringe needles and washed with PBS. 5 ml of colla- 
genase solution (I00 ~tg/ml in PBS) was added to the tissue sample for 
30 min at 37°C on a rotating platform. The suspension was cooled on 
ice and carefully pipetted 2-3 times using a wide-tip pipette to dis- 
connect he cells from the stroma. The cell suspension was filtered 
through cotton wool to remove macroscopic debris and cell aggre- 
gates. Cells were washed twice with PBS using centrifugation at 
250×g for 10 min and resuspended in DMEM supplemented with 
10% FCS (10 6 cells/ml). 
Expression of I]-gal in the electroinjected liver cells was detected 
using an ImaGene Green Gene Expression Kit (Molecular Probes, 
Eugene, OR) according to the protocol of the manufacturer. Briefly, 
cells were treated with chloroquine for 30 min, washed with DMEM 
by centrifugation a d resuspended in DMEM supplemented with 10% 
FCS. The lipophilic ~-gal substrate, 5-dodecanoylaminofluorescein di- 
~-galactopyranoside (Ca2FDG), was added at a final concentration f
60 ItM, and cells were incubated for 1 h at 37°C. Cells were then 
washed once with PBS and analyzed by flow cytometry. The assays 
were made using an Epics Elite flow cytometer (Coulter, Hialeah, FL). 
2. 7. Cytochemical ssay of fJ-galactosidase 
Tissue specimens were removed from animals and immediately 
stored at 4°C. Within 1 h, specimens were embedded in tissue freze 
medium (Triangle Biomedical Science, Durham, NC) and frozen in 
liquid nitrogen. Several (3-5) frozen sections (7 Itm thick) were cut 
from each sample. After cutting, each section was fixed for 15 min in 
2.5% glutaraldehyde and then washed three times in PBS (Mediatech, 
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Fig. 1. Field strength dependence of luciferase xpression i  rat liver 
after electroinjection of 100 ktg of DNA expressing luciferase. An- 
esthetized rats were incised and both halves of the median lobe 
were exposed (see Section 2). 100 Itl of DNA in 100 Itl of saline 
were injected beneath the surface of the median lobe at a single lo- 
cation. 1.5 min after injection the electrodes were placed on the tis- 
sue and 6 pulses of 99 Its duration were administered in the form of 
a rotating electric field. Expression was assayed in tissue samples 
taken by first killing the animals 48 h after the procedure. Expres- 
sion was measured by luminescence emission in the presence of 
CoA-luciferin as substrate (see Section 2). 
Washington, DC). Specimens were then incubated at 37°C in the 
presence of 0.2% 5-bromo-4-chloro-3-indolyl-13-o-galactopyranoside 
(X-GAL) for 24 h. Then, each specimen was washed again with 
PBS and viewed using light microscopy. 
3. Results 
Expression of firefly luciferase (Luc) and of [3-galactosidase 
in the electroinjected liver tissue was used to evaluate the 
efficiency of intracellular DNA delivery. Electroinjection of 
plasmid DNA in the liver resulted in strong enzyme expres- 
sion 48 h later. Optimal gene expression was achieved at field 
strengths between 1.0 and 1.5 kV/cm (Fig. 1). Electric field 
strengths below 1 kV/cm were insufficient for the permeabili- 
zation of liver cells. Field strengths higher than 1.5 kV/cm 
resulted in a strong decrease of the detected Luc expression, 
probably as a result of inefficient heat dissipation in the liver 
and necrosis of the electroinjected tissue. The level of expres- 
sion in electroinjected cells was probably higher than that we 
report, because all measurements were performed in liver tis- 
sue homogenates from an area larger than the electroinjected 
region. Accurate location of the electroinjected area was lim- 
ited by the fact that electrode marks on the tissue disappear 
within a few days. The level of luciferase activity in tissue 
reached a maximal value at 48 h, followed by a decrease to 
less than 5% of the peak activity during the first week. This 
level of expression remained stable during the next two weeks 
(Fig. 2). DNA injected in the liver with electroporation was 
also expressed albeit much more weakly; within 14 days, ex- 
pression could not be reliably detected in non-electroporated 
tissue. 
Gene transfer using in vivo electroporation strongly de- 
pended on the amount  of DNA injected into the tissue (Fig. 
3). There was an apparent sharp maximum for marker expres- 
sion at 25 gg of plasmid DNA per tissue injection. This un- 
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Fig. 2. Time course of luciferase xpression i  rat liver after electro- 
injection of 100 p.g of DNA containing the luciferase gene. Proce- 
dures as above. Field strength=l kV/cm. Expression measured by 
luminescence. 
expected ose dependence in vivo is different from in vitro 
electroporation, i  which the DNA dose dependence exhibits 
saturation [15]. 
One important advantage of electroporation in vitro is the 
high efficiency of intracellular DNA delivery. In order to 
quantitate the expression efficiency of the in vivo procedure, 
the liver tissue was electroinjected with the ~-gal gene, and 
hepatocytes were isolated from the dissected liver tissue after 
collagenase treatment [2]. The isolated cells were treated with 
chloroquine, to block lysosome activity, followed by incuba- 
tion with the lipophilic [~-gal substrate C12FDG (5-dodeca- 
noylamino fluorescein di-I]-galacto pyranoside). 
The activity of the reporter gene was assayed using flow 
cytometry and histochemical staining. Cells isolated from elec- 
troporated liver tissue in the absence of the I]-gal reporter 
gene showed no 13-gal activity whereas the cell suspension 
prepared from 13-gal-transfected liver contain over 30% 13- 
gal-positive cells (Fig. 4). The actual number of efficiently 
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Fig. 3. Dose dependence of luciferase xpression in rat livers after 
electroinjection of different amounts of DNA expressing luciferase. 
The field strength of pulses was 1 kV/cm. Procedures as above. 
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Fig. 4. Flow cytometric assay of ~-galactosidase expression in rat 
livers after administration f 25 p.g DNA. Expression was detected 
using an Ima-Gene Green Gene Expression Kit (Molecular Probes, 
Eugene, OR). The lipophilic ~-gal substrate C12 FDG (5-dodeca- 
noylaminofluorescein d q3-galactopyranoside) wasadded to the cell 
suspension as in Section 2. Flow diagrams were obtained using an 
Epics Coulter cytofluorometer. (A) 25 gg of DNA encoding ~-galac- 
tosidase injected without electroporation. (B) 25 p.g of DNA encod- 
ing [3-galactosidase injected followed by electroporation. Field 
strength = 1.0 kV/cm (see Section 2). 
transfected cells in the electroinjected area might be signifi- 
cantly higher due to technical difficulties in locating the trans- 
fected tissue. 
Histochemical staining of the electroporated liver tissue 
yielded a similar calculated efficiency for in vivo transfection 
of hepatocytes: 30-35% of hepatocytes in the electroinjected 
area demonstrated [3-gal activity (results not shown). This 
efficiency of transfection was identical to the best transfection 
obtained in vitro and was significantly higher than any in vivo 
transfection reported to date [14]. 
4. Discussion 
The results presented emonstrate hat in vivo electropora- 
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tion provides an efficient approach for tissue-targeted local 
gene expression with a relatively high efficiency of tranfection. 
The total number of transfected cells in our experiments i
limited only by the geometry of the applied electrical field. 
The control experiments also confirmed the reports that direct 
hepatic DNA injection results in the detectable l vel of gene 
expression. However, electroporation appeared significantly 
more effÉcient than gene transfer by simple injection, the levels 
of expression being much higher and more stable with time. 
Histological examination and histochemical 13-gal staining 
of electroinjected liver tissue suggested that electroinjection 
with field strengths between 1.0 and 1.5 kV/cm does not pro- 
duce any tissue damage, and expressing cells seem to be 
broadly and randomly distributed within the electroinjected 
organ area. This broad distribution of marker expression is 
different from expression reported after simple DNA injec- 
tion, in which gene transfer and expression occurred only 
along the track of the injection needle [14]. 
Efficient gene transfer and expression i  relatively extended 
macroscopic organ areas makes in vivo electroinjection an 
attractive approach for local gene cancer therapy [14]. Our 
results suggest hat in vivo electroporation may be effective 
in transfecting a sufficient proportion of cells in tumors acces- 
sible to the electrodes to be of therapeutic nterest [16]. 
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